Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of transgenic miR-32 expression on hiMYC-driven prostate cancer in vivo

ABSTRACT: Effect of transgenic miR-32 expression on hiMYC-driven prostate cancer in vivo

PROVIDER: PRJNA716275 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Effect of transgenic miR-32 expression on hiMYC-driven prostate cancer in vivo

Project description:We compare the overall gene expression of transgenic mice expressing the MYC oncogene (hiMYC mice) to induce tumorigenesis in the mouse prostate with mice having transgenic expression of the microRNA miR-32 in hiMYC background to determine whether increased expression of miR-32 influences growth or phenotype in prostate adenocarcinoma in vivo.

2021-03-23 | GSE169323 | GEO

Transgenic expression of miR-32 in mouse dorsolateral prostate

Project description:Transcriptional profiling of dorsolateral prostate of mice with prostate-specific transgenic expression of miR-32 compared with wild type mice.

2017-06-27 | GSE100476 | GEO

Transgenic expression of miR-32 in mouse ventral prostate

Project description:Transcriptional profiling of ventral prostate of mice with prostate-specific transgenic expression of miR-32 compared with wild type mice.

2017-06-27 | GSE100475 | GEO

Transgenic expression of miR-32 in mouse ventral and dorsolateral prostate

Project description:Transgenic expression of miR-32 in mouse ventral and dorsolateral prostate

| PRJNA391922 | ENA

Transgenic expression of miR-32 in mouse ventral and dorsolateral prostate

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-06-27 | GSE100477 | GEO

Gene Expression Analysis of Transgenic Myc-Driven Liver Tumor Formation and Regression

Project description:Gene expression changes were examined in transgenic MYC-driven liver cancers at different time points as tumors formed and upon early regression. Time points evaluated include: Control (non-tumor bearing), Pre-tumor (mice were removed from doxyclycine in their diet to induce MYC oncogene expression for 4-5 weeks), Tumor (tumor nodules from mice that had been off of doxycycline for 8-9 weeks) and Early tumor regression (tumor-bearing mice were placed back on doxycycline for 72 hrs to inhibit MYC oncogene expresion). MYC-Driven Mouse Tumor Models are described in Schahaf, et al., Nature, 2004 and Goga, et al., Nature Medicine, 2007. 11 Total Samples: 3 Control, 4 Pre-Tumor, 4 Tumor, 4 Early Tumor Regression. Control = LAP-tTA transgenic mice. Others = TRE-MYC x LAP-tTA double transgenic mice (doxy off).

2011-07-06 | E-GEOD-28198 | biostudies-arrayexpress

Searching targets for miR-32 and miR-148a

Project description:Expression profiling of miR-32 or miR-148a transfected LNCaP cells.

2012-03-29 | E-MEXP-2943 | biostudies-arrayexpress

Xylella fastidiosa 32 strain:32

Project description:Xylella fastidiosa 32 strain:32 Genome sequencing and assembly

| PRJNA171052 | ENA

Gene Expression Analysis of Transgenic Myc-Driven Liver Tumor Formation and Regression

2011-07-06 | GSE28198 | GEO

16-32-00914

Project description:16-32-00914 Map

| PRJNA446039 | ENA